Stewart Allison A, Barrett Jennifer G, Byron Christopher R, Yates Angela C, Durgam Sushmitha S, Evans Richard B, Stewart Matthew C
Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL 61802, USA.
Am J Vet Res. 2009 Jun;70(6):750-7. doi: 10.2460/ajvr.70.6.750.
To compare viability and biosynthetic capacities of cells isolated from equine tendon, muscle, and bone marrow grown on autogenous tendon matrix.
Cells from 4 young adult horses.
Cells were isolated, expanded, and cultured on autogenous cell-free tendon matrix for 7 days. Samples were analyzed for cell viability, proteoglycan synthesis, collagen synthesis, and mRNA expression of collagen type I, collagen type III, and cartilage oligomeric matrix protein (COMP).
Tendon- and muscle-derived cells required less time to reach confluence (approx 2 weeks) than did bone marrow-derived cells (approx 3 to 4 weeks); there were fewer bone marrow-derived cells at confluence than the other 2 cell types. More tendon- and muscle-derived cells were attached to matrices after 7 days than were bone marrow-derived cells. Collagen and proteoglycan synthesis by tendon- and muscle-derived cells was significantly greater than synthesis by bone marrow-derived cells. On a per-cell basis, tendon-derived cells had more collagen synthesis, although this was not significant. Collagen type I mRNA expression was similar among groups. Tendon-derived cells expressed the highest amounts of collagen type III and COMP mRNAs, although the difference for COMP was not significant.
Tendon- and muscle-derived cells yielded greater cell culture numbers in shorter time and, on a per-cell basis, had comparable biosynthetic assays to bone marrow-derived cells. More in vitro experiments with higher numbers may determine whether tendon-derived cells are a useful resource for tendon healing.
比较从马的肌腱、肌肉和骨髓中分离出的细胞在自体肌腱基质上生长时的活力和生物合成能力。
4匹年轻成年马的细胞。
分离细胞、进行扩增,并在自体无细胞肌腱基质上培养7天。对样本进行细胞活力、蛋白聚糖合成、胶原蛋白合成以及I型胶原蛋白、III型胶原蛋白和软骨寡聚基质蛋白(COMP)的mRNA表达分析。
与骨髓来源的细胞(约3至4周)相比,肌腱和肌肉来源的细胞达到汇合所需时间更短(约2周);汇合时骨髓来源的细胞比其他两种细胞类型更少。7天后,附着在基质上的肌腱和肌肉来源的细胞比骨髓来源的细胞更多。肌腱和肌肉来源的细胞合成胶原蛋白和蛋白聚糖的能力明显高于骨髓来源的细胞。按每个细胞计算,肌腱来源的细胞胶原蛋白合成更多,尽管差异不显著。各组I型胶原蛋白mRNA表达相似。肌腱来源的细胞III型胶原蛋白和COMP mRNA表达量最高,尽管COMP的差异不显著。
肌腱和肌肉来源的细胞在更短时间内产生了更多的细胞培养数量,并且按每个细胞计算,其生物合成检测结果与骨髓来源的细胞相当。更多数量的体外实验可能会确定肌腱来源的细胞是否是肌腱愈合的有用资源。